PAYING FOR CURES: AN ANALYSIS OF INNOVATIVE ACCESS AGREEMENTS FOR LICENSED GENE THERAPIES

被引：0
|
作者：
Hogg, L. [1 ]
Richards, M. [1 ]
机构：
[1] Ipsos, London, England
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PBI77
引用
收藏
页码：S431 / S431
页数：1
相关论文
共 50 条
  • [31] Understanding the pathophysiology of hemodialysis access problems as a prelude to developing innovative therapies
    Diskin, Charles J.
    Stokes, Thomas J.
    Dansby, Linda M.
    Radcliff, Lautrec
    Carter, Thomas B.
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2008, 4 (11): : 628 - 638
  • [32] Understanding the pathophysiology of hemodialysis access problems as a prelude to developing innovative therapies
    Charles J Diskin
    Thomas J Stokes
    Linda M Dansby
    Lautrec Radcliff
    Thomas B Carter
    Nature Clinical Practice Nephrology, 2008, 4 : 628 - 638
  • [33] DRUG ACCESS REQUESTS FOR INNOVATIVE THERAPIES FOR PEDIATRIC ONCOLOGY PATIENTS IN CANADA
    Judd, Sandra
    Revon-Riviere, Gabriel
    Deyell, Rebecca J.
    Vanan, Magimairajan Issai
    Pecheux, Lucie
    Zorzi, Alexandra P.
    Santiago, Raoul
    Tran, Thai Hoa
    Grover, Stephanie A.
    Cohen-Gogo, Sarah
    Morgenstern, Daniel
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S317 - S318
  • [34] Innovative patient access schemes for the adoption of new technology: risk-sharing agreements
    Espin, Jaime
    Oliva, Juan
    Manuel Rodriguez-Barrios, Jose
    GACETA SANITARIA, 2010, 24 (06) : 491 - 497
  • [35] Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada
    Judd, Sandra
    Revon-Riviere, Gabriel
    Grover, Stephanie A.
    Deyell, Rebecca J.
    Vanan, Magimairajan Issai
    Lewis, Victor A.
    Pecheux, Lucie
    Zorzi, Alexandra P.
    Goudie, Catherine
    Santiago, Raoul
    Tran, Thai Hoa
    Abbott, Lesleigh S.
    Brossard, Josee
    Moorehead, Paul
    Alvi, Saima
    Portwine, Carol
    Denburg, Avram
    Whitlock, James A.
    Cohen-Gogo, Sarah
    Morgenstern, Daniel A.
    CANCER MEDICINE, 2024, 13 (03):
  • [36] Exploring the boundaries of autonomy and the ‘right’ to access innovative stem cell therapies
    Lysaght T.
    Richards B.
    Muralidharan A.
    Asian Bioethics Review, 2017, 9 (1-2) : 45 - 60
  • [37] NEW TOOKS FOR OLD PROBLEMS: THE JOINT VENTURE AGREEMENTS AND THEIR IMPACT ON ACCESS TO INNOVATIVE MEDICINES
    Espin Balbino, J.
    GACETA SANITARIA, 2009, 23 : 186 - 187
  • [38] ARE TRADITIONAL MANAGED ENTRY AGREEMENTS SUITABLE FOR POTENTIALLY, CURATIVE GENE/CELL THERAPIES?
    Colasante, W.
    VALUE IN HEALTH, 2018, 21 : S192 - S192
  • [39] The use of innovative payment mechanisms for gene therapies in Europe and the USA
    Jorgensen, Jesper
    Kefalas, Panos
    REGENERATIVE MEDICINE, 2021, 16 (04) : 405 - 422
  • [40] ARE THE HURDLES TOO HIGH FOR ACCESS TO GENE THERAPIES IN THE UK?
    Sideris, E.
    Holdgate, O.
    Patel, A.
    Rouse, P.
    Guest, S.
    VALUE IN HEALTH, 2023, 26 (12) : S324 - S324
12345